Allison Hoffman, MD
Dermatology · Minneapolis, MNNPI 1659496586
Payments from drug & device makers
Across 41 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$106
- Regeneron Healthcare Solutions, Inc.$78
- Amgen$68
- LEO Pharma Inc.$61
- Arcutis Biotherapeutics, Inc.$45
- Johnson & Johnson$45
- plus $260 from 11 others
What the payments were for
- Food & beverage$664100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 6 | $106 |
| Regeneron Healthcare Solutions, Inc. | 5 | $78 |
| Amgen | 4 | $68 |
| LEO Pharma Inc. | 4 | $61 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
| Johnson & Johnson | 3 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Biofrontera Inc. | 2 | $38 |
| Galderma Laboratories, L.p. | 2 | $29 |
| UCB, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
How this compares
$664 in reported general payments places this provider in the 70th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 165 | $2,637 |
| Clobetasol Propionate | 25 | $1,291 |
| Clindamycin Phosphate | 29 | $1,115 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 19 | $933 |
| Fluorouracil | 12 | $864 |
| ValacyclovirValacyclovir Hcl | 29 | $775 |
| Metronidazole | 14 | $674 |
| Fluticasone Propionate | 26 | $576 |
| Imiquimod | 17 | $556 |
| Triamcinolone Acetonide | 55 | $318 |
| Hydrocortisone | 44 | $205 |
| Cephalexin | 14 | $69 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Minneapolis
- Maria HordinskyMinneapolis$2.1M
- Margareth Pierre-LouisMinneapolis$456K
- Noah GoldfarbMinneapolis$359K
- Paul BigliardiMinneapolis$237K
- David PearsonMinneapolis$164K
- Kimberly BohjanenMinneapolis$93K
- Brittney SchultzMinneapolis$75K
- Brian ZelicksonMinneapolis$54K
- Sara HylwaMinneapolis$5K
- Timothy AllenMinneapolis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.